In this study we describe some biological effects of IL-34, a newly discovered cytokine. We show that 11-34 stimulates monocyte cell viability and directly modulates the number and function of monocytes and regulates myeloid cell growth and differentiation. Moreover, since IL-34 in mice is involved in osteoporosis, an antagonist of this cytokine could be beneficial for the treatment of this disease. Copyright © by Biolife, s.a.s.
CITATION STYLE
Castellani, M. L., Anogeianaki, A., Felaco, P., Toniato, E., De Lutiis, M. A., Shaik, B., … Cerulli, G. (2010). IL-34 a newly discovered cytokine. European Journal of Inflammation. Biolife s.a.s. https://doi.org/10.1177/1721727X1000800202
Mendeley helps you to discover research relevant for your work.